Donor Enhancement With Plerixafor Post Myeloablative Allogeneic Transplant
Clinical trial NCT01280955 · COMPLETED
Trial details
- NCT number
- NCT01280955
- Sponsor
- Mitchell Horwitz, MD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2014-09-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.